- Home
- AHT vs ESLA Comparison
AHT vs ESLA Comparison
Compare AHT & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHT
- ESLA
- Stock Information
- Founded
- AHT 2003
- ESLA 2021
- Country
- AHT United States
- ESLA United States
- Employees
- AHT N/A
- ESLA N/A
- Industry
- AHT Real Estate Investment Trusts
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AHT Real Estate
- ESLA Health Care
- Exchange
- AHT Nasdaq
- ESLA Nasdaq
- Market Cap
- AHT 37.2M
- ESLA 35.5M
- IPO Year
- AHT 2003
- ESLA N/A
- Fundamental
- Price
- AHT $6.30
- ESLA $0.82
- Analyst Decision
- AHT
- ESLA Strong Buy
- Analyst Count
- AHT 0
- ESLA 1
- Target Price
- AHT N/A
- ESLA $16.00
- AVG Volume (30 Days)
- AHT 23.6K
- ESLA 18.2K
- Earning Date
- AHT 07-30-2025
- ESLA 08-20-2025
- Dividend Yield
- AHT N/A
- ESLA N/A
- EPS Growth
- AHT N/A
- ESLA N/A
- EPS
- AHT N/A
- ESLA N/A
- Revenue
- AHT $1,129,071,000.00
- ESLA N/A
- Revenue This Year
- AHT N/A
- ESLA N/A
- Revenue Next Year
- AHT N/A
- ESLA N/A
- P/E Ratio
- AHT N/A
- ESLA N/A
- Revenue Growth
- AHT N/A
- ESLA N/A
- 52 Week Low
- AHT $5.20
- ESLA $0.63
- 52 Week High
- AHT $11.99
- ESLA $1.78
- Technical
- Relative Strength Index (RSI)
- AHT 45.32
- ESLA 42.20
- Support Level
- AHT $6.46
- ESLA $0.82
- Resistance Level
- AHT $6.47
- ESLA $0.95
- Average True Range (ATR)
- AHT 0.24
- ESLA 0.06
- MACD
- AHT -0.05
- ESLA -0.00
- Stochastic Oscillator
- AHT 13.70
- ESLA 23.49
About AHT Ashford Hospitality Trust Inc
Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides real estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.